In an opinion piece from the Economic Times, Jogin Desai, founder and CEO of Eyestem, says India's biotechnology sector is currently riding a crest of entrepreneurial success and innovation. In the span of eight years, India’s bioeconomy vaulted from $10 billion to $80 billion, and the number of biotech startups rose...
India’s Biotech Startup Eyestem Raises $6.4 Mn
Headquartered in Bangalore and Delaware, cell therapy startup Eyestem secured $6.4 million in its Series A funding round at a post-money valuation of $46.4 million. The funding was led by three Indian pharma majors- Biological E. Limited, Alkem, NATCO and Anurag and Karan Bagaria, promoters of Kemwell Biopharma. Existing investors...